Kay Rittenbach (PhD) is the Assistant Scientific Director, Addiction & Mental Health Strategic Clinical Network, Alberta Health Services
Node Funded Project
Title: Naloxone Take-Home Kit Program Evaluation
Principal Investigator: Kay Rittenbach, University of Alberta
Ariel Ducey (University of Calgary), Carla McLean (AHS)
Alberta Health Services’ (AHS) mission is to provide a patient-focused, quality health system that is accessible and sustainable for all Albertans. Alberta is taking steps to make the lifesaving opioid overdose reversal drug, naloxone, available to opioid users across the province. We have committed to provide funding support to a graduate student to participate and develop research skills applied to the priority area of Naloxone Take Home Kit Program evaluation. This capacity building initiative will support a trainee towards the generation of evidence to drive decision-making, ongoing health care system improvement, health policy improvement, and sustainability. The results of the proposed project will also improve the quality of care delivery within the Health Quality Council of Alberta’s six domains of quality: appropriateness, accessibility, effectiveness, efficiency, safety, and acceptability.